TruScreen to test 130,000 Chinese oil workers, expects $1.1 million in sales

TruScreen to test 130,000 Chinese oil workers, expects $1.1 million in sales
By Suze Metherell June 11 (BusinessDesk) - NZAX-listed TruScreen, the cervical cancer test developer, has been selected by Chinese oil company Sinopec to screen 130,000 of its female workers, in a deal which could be worth $1.1 million in sales.  The first order for 8,100 single use sensor tests, worth $74,000, has been received and the screening programme is expected to run until the end of next year, the Auckland-based company said in a statement. The deal with Sinopec, one of China's largest oil and petroleum product producers, is a jo...